Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $40.62 USD
Change Today -0.49 / -1.19%
Volume 458.0K
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David P. Southwell

Director, Chairman of Compensation Committee and Member of Audit Committee,PTC Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 36 board members in 3 different organizations across 7 different industries.

See Board Relationships


Mr. David P. Southwell has been the Chief Executive Officer and President of Inotek Pharmaceuticals Corporation since July 2014. Mr. Southwell is a Consultant of Sepracor, Inc. He is a Partner of BioNevia Inc. He has more than twenty years of experience and significant accomplishment in financial strategy, planning and business development. He served as the Chief Financial Officer, Principal Accounting Officer and Executive Vice President at Human Genome Sciences Inc. ...

Read Full Background

Corporate Headquarters*

100 Corporate Court
South Plainfield, New Jersey 07080

United States

Phone: 908-222-7000
Fax: 908-222-7231

Board Members Memberships*

Director, Chairman of Compensation Committee and Member of Audit Committee
Independent Director, Chairperson of Governance Committee, Chairperson of Compensation Committee and Member of Audit Committee
Chief Executive Officer, President and Director


Rice University
Tuck School of Business at Dartmouth

Other Affiliations*

Annual Compensation*

Total Annual Compensation$154,097

Stock Options*

Unexercisable Options398,497
Total Number of Options398,497

Total Compensation*

Total Annual Cash Compensation$154,097
Total Short Term Compensation$154,097
Total Calculated Compensation$1,480,097
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PTCT:US $40.62 USD -0.49


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PTC THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at